Home
Scholarly Works
The health economics of lung cancer and an...
Conference

The health economics of lung cancer and an estimate of the cost effectiveness of single agent gemcitabine in stage IV NSCLC

Authors

Evans WK

Volume

31A

Pagination

pp. 1057-1057

Publisher

PERGAMON-ELSEVIER SCIENCE LTD

Publication Date

November 1, 1995

Conference proceedings

EUROPEAN JOURNAL OF CANCER

ISSN

0959-8049

Labels

Fields of Research (FoR)

Contact the Experts team